Stockscreener 앱 받기
15.85
1.56%
0.14
전일 마감가:
$15.71
열려 있는:
$17.32
하루 거래량:
1.86M
Relative Volume:
5.32
시가총액:
$320.46M
수익:
$80.54M
순이익/손실:
$-62.79M
주가수익비율:
-5.0748
EPS:
-3.1233
순현금흐름:
$20.76M
1주 성능:
+14.05%
1개월 성능:
+28.05%
6개월 성능:
-9.91%
1년 성능:
-45.00%
1일 변동 폭
$14.82
$17.32
1주일 범위
$13.79
$17.32
52주 변동 폭
$11.09
$34.01
Simulations Plus Inc Stock (SLP) Company Profile
명칭
Simulations Plus Inc
전화
661-723-7723
주소
800 PARK OFFICES DRIVE, SUITE 401, RESEARCH TRIANGLE PARK, CA
Compare SLP vs VEEV, BTSG, TEM, HQY, DOCS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SLP
Simulations Plus Inc
|
15.86 | 317.43M | 80.54M | -62.79M | 20.76M | -3.1233 |
VEEV
Veeva Systems Inc
|
169.20 | 27.94B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
52.34 | 9.98B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
51.00 | 9.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
83.00 | 6.98B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
25.54 | 4.76B | 637.78M | 239.40M | 307.21M | 1.1909 |
Simulations Plus Inc Stock (SLP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-18 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-09-30 | 개시 | TD Cowen | Hold |
| 2025-07-15 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-11-15 | 개시 | Stephens | Overweight |
| 2024-07-29 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-07-16 | 개시 | JMP Securities | Mkt Perform |
| 2024-06-28 | 개시 | William Blair | Outperform |
| 2023-05-09 | 개시 | BTIG Research | Buy |
| 2021-10-26 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2021-01-12 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2020-10-16 | 개시 | Raymond James | Outperform |
| 2020-09-08 | 개시 | Oppenheimer | Outperform |
| 2020-01-06 | 개시 | Craig Hallum | Buy |
모두보기
Simulations Plus Inc 주식(SLP)의 최신 뉴스
Simulations Plus Collaborates With Nvidia During AI Drug Modeling Push - Benzinga
Simulations Plus partners with Nvidia on AI drug development By Investing.com - Investing.com Nigeria
Simulations Plus stock surges 28% on NVIDIA collaboration - Investing.com
Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows - Business Wire
Insider Sell Alert: DiBella John Anthony II Sells Shares of Simu - GuruFocus
[Form 4] Simulations Plus, Inc. Insider Trading Activity - Stock Titan
Simulations Plus (SLP) insiders sell 15,000 shares in planned trade - Stock Titan
Do options traders know something about Simulations Plus stock we don't? - MSN
[144] Simulations Plus, Inc. SEC Filing - Stock Titan
(SLP) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Do Options Traders Know Something About Simulations Plus Stock We Don't? - TradingView
Simulations Plus (SLP) director receives 2,117-share equity grant as compensation - Stock Titan
Director Sharlene Evans receives 2,117 SLP shares in equity grant - Stock Titan
Director at Simulations Plus (SLP) receives 2,117-share stock grant - Stock Titan
Simulations Plus (SLP) director awarded 2,117 shares as equity compensation - Stock Titan
SLP Stock Price, Quote & Chart | SIMULATIONS PLUS INC (NASDAQ:SLP) - ChartMill
AI in Predictive Toxicology Research Report 2026 Featuring - GlobeNewswire
AI in Predictive Toxicology Research Report 2026 Featuring Certara, Schrodinger, Instem, Simulations Plus, Lhasa, ChemaxonGlobal Forecast to 2030 and 2035 - Yahoo Finance UK
Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight - GlobeNewswire Inc.
Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Latest SLP NewsSimulations Plus Announces Quarterly Cash Di... - Stock Titan
Simulations Plus Q2 2026 earnings preview - MSN
Certara Strategic Business Divestiture Comes At Right Time, Says Analyst - Sahm
(SLP) Risk Channels and Responsive Allocation - Stock Traders Daily
Simulations Plus shares drop over 12% premarket as Q3 revenue forecast misses expectations - MSN
SLP Simulations Plus posts strong Q1 2026 results, shares rise over four percent on double digit EPS and revenue gains.Debt/Equity - Xã Thanh Hà
Simulations Plus partners with Lonza and FDA on drug formulation research - Investing.com Nigeria
Simulations Plus (SLP) Partners with FDA and Lonza for Drug Perf - GuruFocus
Simulations Plus enters funded research collaboration with Lonza, FDA - TipRanks
Simulations Plus partners with Lonza and FDA on drug formulation research By Investing.com - Investing.com South Africa
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products - Business Wire
Craig-Hallum Maintains Simulations Plus(SLP.US) With Buy Rating - Moomoo
Simulations Plus (SLP) Completes Successful Spring School Traini - GuruFocus
What Happened to Simulations Plus (SLP) Stock Today (Wavering) 2026-04-20Continuation Signals - Cổng thông tin điện tử tỉnh Tây Ninh
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School - 01net
Simulations Plus Inc Announces Completion of 2026 Spring School Global Training Initiative - marketscreener.com
Simulations Plus Reports Strong Fiscal Second Quarter Growth - HarianBasis.co
Here’s Simulations Plus Inc (SLP)’s Vision for AI in Drug Development - Insider Monkey
Simulations Plus, Children's Place and 3 stocks to watch heading into Friday - MSN
Simulations Plus (SLP) Stock Public Float (+1.77%) 2026-04-18Continuation Pattern - Cổng thông tin điện tử tỉnh Tây Ninh
Simulations Plus, Inc. (SLP) Stock Analysis: Exploring a 67.61% Potential Upside in Healthcare Software Solutions - DirectorsTalk Interviews
Simulations Plus, Inc. (NASDAQ: SLP) Q2 2026 earnings call transcript - MSN
Insider Sell: DiBella John Anthony II Sells Shares of Simulations Plus Inc (SLP) - GuruFocus
John Anthony Dibella II Sells 1,000 Shares of Simulations Plus (NASDAQ:SLP) Stock - MarketBeat
DiBella, Simulations Plus CRO, sells $13370 in SLP stock By Investing.com - Investing.com Canada
Simulations Plus (SLP) CRO sells 1,000 shares via Rule 10b5-1 plan - Stock Titan
HTPK platform from Simulations Plus targets smarter early compound selection at DDC - Traders Union
Simulations Plus: Better Quarter, Same Doubts (NASDAQ:SLP) - Seeking Alpha
Simulations Plus Inc (SLP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Simulations Plus Inc 주식 (SLP) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| WOLTOSZ WALTER S | Director |
May 04 '26 |
Sale |
15.13 |
15,000 |
226,950 |
3,267,800 |
2.18%
2.11%
자본화:
|
볼륨(24시간):